Current Psychopharmacology
Title:Editorial: Glutamatergic Mechanisms in Depression: Focus on D-cycloserine
Volume: 6
Author(s): Andrea R. Durrant and Uriel Heresco-Levy
Affiliation:
Export Options
About this article
Cite this article as:
Durrant R. Andrea and Heresco-Levy Uriel , Editorial: Glutamatergic Mechanisms in Depression: Focus on D-cycloserine, Current Psychopharmacology 2017; 6 (2) . https://dx.doi.org/10.2174/221155600602180102105314
DOI https://dx.doi.org/10.2174/221155600602180102105314 |
Print ISSN 2211-5560 |
Publisher Name Bentham Science Publisher |
Online ISSN 2211-5579 |
Call for Papers in Thematic Issues
Breakthroughs in drug design, development and delivery system for the management of neuro-psychiatric disorders
Neuropsychiatric diseases are one of the main causes of disability, affecting millions of people. Various drugs are used for its treatment, although no effective therapy has been found yet. The blood brain barrier (BBB) significantly complicates drugs delivery to the target cells in the brain tissues. This proposal describes the ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
The Role of Anti-Inflammatory Drugs in Respiratory Diseases - Pirfenidone, Penicillamine, Chloroquine and Chlorambucil
Current Respiratory Medicine Reviews Pharmacologic Inhibition of mTOR Improves Lapatinib Sensitivity in HER2-Overexpressing Breast Cancer Cells with Primary Trastuzumab Resistance
Anti-Cancer Agents in Medicinal Chemistry Glucocorticoid Excess Induces Accumulation of Cardiac Glycogen and Triglyceride: Suggested Role for AMPK
Current Pharmaceutical Design Schizophrenia: From Dopamine to Glutamate and Back
Current Medicinal Chemistry Rediscovery of Caffeine: An Excellent Drug for Improving Patient Outcomes while Fighting WARS
Current Medicinal Chemistry Pharmacological Treatment of ADHD and the Short and Long Term Effects on Sleep
Current Pharmaceutical Design Indoleamine 2,3-dioxygenase (IDO): Biology and Target in Cancer Immunotherapies
Current Cancer Drug Targets Nicotine Effects, Body Weight Concerns and Smoking: A Literature Review
Current Pharmaceutical Design Molecular Mechanisms Determining Opposed Functional States of Microglia
Current Neuropharmacology The Zebrafish Model: Use in Studying Cellular Mechanisms for a Spectrum of Clinical Disease Entities
Current Neurovascular Research Ghrelin in Central Neurons
Current Neuropharmacology Altered Calmodulin Degradation and Signaling in Non-Neuronal Cells from Alzheimer’s Disease Patients
Current Alzheimer Research Reprogrammed Metabolism of Cancer Cells as a Potential Therapeutic Target
Current Pharmaceutical Design Cannabinoid Receptor Type 2 Activation in Atherosclerosis and Acute Cardiovascular Diseases
Current Medicinal Chemistry Spirituality, Religiosity and Addiction Recovery: Current Perspectives
Current Drug Research Reviews Mental Training for Cognitive Improvement in Elderly People: What have We Learned from Clinical and Neurophysiologic Studies?
Current Alzheimer Research Asymptomatic Alzheimers Disease: A Prodrome or a State of Resilience?
Current Alzheimer Research IAPs as a Target for Anticancer Therapy
Current Cancer Drug Targets Opioid Antagonists for Pharmacological Treatment of Gambling Disorder: Are they Relevant?
Current Neuropharmacology Antioxidant Food Supplements and Obesity-Related Inflammation
Current Medicinal Chemistry